Inventor · disambiguated record
Peter Fischer
Also filed as: FISCHER PETER · FISCHER PETER M · FISCHER PETER MARTIN
29 granted patents·21 pending applications·525 citations·filing 1993–2019
97Inventor score
Top patents by PatentIndex Score
50 records- 0192US6531479B2Anti-cancer compoundsCYCLACEL LTD·Filed 2001·Granted Mar 11, 2003·52 cites·23 claims
- 0291US6699854B2Anti-cancer compoundsCYCLACEL LTD·Filed 2002·Granted Mar 2, 2004·40 cites·26 claims
- 0389US6261569B1Retro-, inverso- and retro-inverso synthetic peptide analoguesDEAKIN RES LTD·Filed 1993·Granted Jul 17, 2001·190 cites·16 claims
- 0488US7897605B2Pyrimidine compoundsCYCLACEL LTD·Filed 2008·Granted Mar 1, 2011·14 cites·6 claims
- 0586US7101967B2Transport vectorsCYCLACEL LTD·Filed 2001·Granted Sep 5, 2006·13 cites·28 claims
- 0682US6472507B1Carrier based drug delivery systemCYCLACEL LTD·Filed 1999·Granted Oct 29, 2002·57 cites·40 claims
- 0781US7582642B2Purine derivativesCYCLACEL LTD·Filed 2005·Granted Sep 1, 2009·5 cites·10 claims
- 0881US7427627B2N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl)-N-phenylamines as antiproliferative compoundsCYCLACEL LTD·Filed 2006·Granted Sep 23, 2008·6 cites·25 claims
- 0980US7576091B2Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting protein kinasesCYCLACEL LTD·Filed 2006·Granted Aug 18, 2009·7 cites·17 claims
- 1080US7544689B2Purine derivativesCYCLACEL LTD·Filed 2005·Granted Jun 9, 2009·4 cites·10 claims
- 1180US7262202B2Inhibitors of cyclin dependent kinases as anti-cancer agentCYCLACEL LTD·Filed 2003·Granted Aug 28, 2007·13 cites·41 claims
- 1279US6992169B2Carrier based drug delivery systemCYCLACEL LTD·Filed 2002·Granted Jan 31, 2006·9 cites·40 claims
- 1378US7902361B2Pyrimidin-4-yl-3, 4-thione compounds and their use in therapyCYCLACEL LTD·Filed 2006·Granted Mar 8, 2011·7 cites·28 claims
- 1478US7432260B2Pyrimidine compoundsCYCLACEL LIMTED·Filed 2004·Granted Oct 7, 2008·17 cites·34 claims
- 1578US7388015B2N-(4-(4-methylthiazol-5-yl)pyrimidin-2-yl)-N-phenylamines as antiproliferative compoundsCYCLACEL LTD·Filed 2004·Granted Jun 17, 2008·13 cites·25 claims
- 1676US7449544B2p21 peptidesCYCLACEL LTD·Filed 2003·Granted Nov 11, 2008·11 cites·9 claims
- 1771US8846696B2Purine derivativesFISCHER PETER MARTIN·Filed 2009·Granted Sep 30, 2014·2 cites·6 claims
- 1868US7153931B1Transport vectorsCYCLACEL LTD·Filed 1999·Granted Dec 26, 2006·15 cites·93 claims
- 1968US5830867AHemoregulatory peptides for stimulating the myelopoietic systemSMITHKLINE BEECHAM CORP·Filed 1994·Granted Nov 3, 1998·27 cites·13 claims
- 2067US8357673B24-arylazo-3,5-diamino-pyrazole compounds and use thereofUNIV PALACKEHO·Filed 2005·Granted Jan 22, 2013·2 cites·2 claims
- 2165US7612079B22,6,9-substituted purine derivatives and their use in the treatment of proliferative disordersCYCLACEL LTD·Filed 2003·Granted Nov 3, 2009·4 cites·22 claims
- 2252US2007185134A1Inhibitors of cyclin dependent kinases as anti-cancer agentCYCLACEL LTD·Filed 2006·Application pending·0 cites
- 2351US2011092490A1Pyrimidines, triazines and their use as pharmaceutical agentsUNIV NOTTINGHAM·Filed 2009·Application pending·0 cites
- 2450US6124298APyrazinedicarboxylic-acid derivatives as cell proliferation regulatorsNYCOMED IMAGING AS·Filed 1999·Granted Sep 26, 2000·4 cites·9 claims
- 2547US2006293245A1P21 derived peptides and uses thereofCYCLACEL LTD·Filed 2006·Application pending·0 cites
- 2646US7312356B2MedicamentCYCLACEL LTD·Filed 2004·Granted Dec 25, 2007·0 cites·15 claims
- 2746US6432685B1Method for the oxidation of substituted trimethylcyclohexenyl compounds with bacteria of the family StreptomycetaceaeBASF AG·Filed 1999·Granted Aug 13, 2002·4 cites·8 claims
- 2845US2005153894A1p21 peptidesCYCLACEL LTD·Filed 2004·Application pending·0 cites
- 2944US2005215548A1Bisarylsulfonamide compounds and their use in cancer therapyCYCLACEL LTD·Filed 2004·Application pending·0 cites
- 3043US2006281687A1Cyclin groove inhibitorsANDREWS MARTIN J·Filed 2006·Application pending·0 cites
- 3143US2009215805A14-Heteroaryl Pyrimidine Derivatives and use thereof as Protein Kinase InhibitorsCYCLACEL LTD·Filed 2006·Application pending·0 cites
- 3242US5972926APyrazine fused to a cyclic peptideNYCOMED IMAGING AS·Filed 1995·Granted Oct 26, 1999·2 cites·8 claims
- 3342US2008132484A1Method for Identifying Inhibitors Using a Homology Model of Polo-Like Kinase 1CYCLACEL LTD·Filed 2004·Application pending·0 cites
- 3440US2009318446A14-(1H-Indol-3-yl)-Pyrimidin-2-Ylamine Derivatives and Their Use in TherapyCYCLACEL LTD·Filed 2006·Application pending·0 cites
- 3539US2006241297A1Pyridinylamino-pyrimidine derivatives as protein kinase inhibitorsCYCLACEL LTD·Filed 2006·Application pending·0 cites
- 3639US2003036628A1p21 peptidesFiled 2000·Application pending·0 cites
- 3738US2008318954A1CompoundsCYCLACEL LTD·Filed 2005·Application pending·0 cites
- 3837US2007021419A12-Aminophenyl-4-phenylpyrimidines as kinase inhibitorsCYCLACEL LTD·Filed 2006·Application pending·0 cites
- 3937US2006040997A1Benzthiazole-3 oxides useful for the treatment of proliferative disordersMCINNES CAMPBELL·Filed 2005·Application pending·0 cites
- 4035US5962408ADisulphide-cyclo- H-Cys-Glu-Gln-Tyr-Cys-OH!, and its use in blood-clotting disordersNYCOMED IMAGING AS·Filed 1995·Granted Oct 5, 1999·4 cites·5 claims
- 4134US2008167385A1Crystal Structure of Human Proliferating Cell Nuclear Antigen (Pcna) and Uses ThereofKONTOPIDIS GEORGE·Filed 2005·Application pending·0 cites
- 4233US2005288307A1Anti-viral compoundsWANG SHUDONG·Filed 2005·Application pending·0 cites
- 4333US2005282843A1Therapeutic applications of 2-substituted 4-heteroarylpyrimidinesWANG SHUDONG·Filed 2005·Application pending·0 cites
- 4432US5837684APeptidesNYCOMED IMAGING AS·Filed 1995·Granted Nov 17, 1998·3 cites·6 claims
- 4531US11530193B2Kinase inhibitorsUNIV MANCHESTER·Filed 2019·Granted Dec 20, 2022·0 cites·38 claims
- 4631US2015051270A1Novel Cyclic Phenoxy Compounds and Improved Treatments for Cardiac and Cardiovascular DiseaseUNIV NOTTINGHAM·Filed 2013·Application pending·0 cites
- 4730US2009137572A12-substituted-4-heteroaryl-pyrimidines useful for the treatment of proliferative disordersWANG SHUDONG·Filed 2005·Application pending·0 cites
- 4827US5948759AFactor VII fragment 82-128 and its use in blood-clotting disordersNYCOMED IMAGING AS·Filed 1995·Granted Sep 7, 1999·0 cites·14 claims
- 4924US2014094493A1Novel Ether Linked Compounds and Improved Treatments for Cardiac and Cardiovascular DiseaseBAKER JILLIAN G·Filed 2012·Application pending·0 cites
- 5022US2013261178A1Phenoxypropanol derivatives and their use in treating cardiac and cardiovascular diseasesMISTRY SHAILESH·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peter Fischer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →